Skip to main content

Table 1 Characteristics of pSS patients and healthy controls

From: A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren’s syndrome

 

pSS

control

p value

n

60

61

 

Female (n)

55

56

1

Age (Y)

46.9 ± 13.16

43.25 ± 11.22

0.46

Anti-SSA antibodies+ (n (%))

41 (68.33)

  

Anti-SSB antibodies+ (n (%))

32 (53.33)

  

IgG (mg/dl)

2039.47 ± 753.85

  

Unstimulated whole salivary flow≤1.5 ml/15 min (n (%))

40 (95.24)

  

Schirmer’s test ≤5 mm per 5 min (n (%))

25 (89.29%)

  

≥ 50 inflammatory cells/4 mm2 of Minor labial salivary gland on biopsy (n (%))

59 (98.33)

  
  1. pSS Primary Sjogren’s syndrome, IgG Immunoglobulin G